Cargando…
Effect of atorvastatin on muscle symptoms in coronary heart disease patients with self-perceived statin muscle side effects: a randomized, double-blinded crossover trial
AIMS: To estimate the effect of atorvastatin on muscle symptom intensity in coronary heart disease (CHD) patients with self-perceived statin-associated muscle symptoms (SAMS) and to determine the relationship to blood levels of atorvastatin and/or metabolites. METHODS AND RESULTS: A randomized multi...
Autores principales: | Kristiansen, Oscar, Vethe, Nils Tore, Peersen, Kari, Wang Fagerland, Morten, Sverre, Elise, Prunés Jensen, Elena, Lindberg, Morten, Gjertsen, Erik, Gullestad, Lars, Perk, Joep, Dammen, Toril, Bergan, Stein, Husebye, Einar, Otterstad, Jan Erik, Munkhaugen, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566260/ https://www.ncbi.nlm.nih.gov/pubmed/32609361 http://dx.doi.org/10.1093/ehjcvp/pvaa076 |
Ejemplares similares
-
Clinical and psychological factors in coronary heart disease patients with statin associated muscle side-effects
por: Peersen, Kari, et al.
Publicado: (2021) -
Unfavourable risk factor control after coronary events in routine clinical practice
por: Sverre, Elise, et al.
Publicado: (2017) -
A novel direct method to determine adherence to atorvastatin therapy in patients with coronary heart disease
por: Kristiansen, Oscar, et al.
Publicado: (2019) -
Plasma concentration of atorvastatin metabolites correlates with low‐density lipoprotein cholesterol reduction in patients with coronary heart disease
por: Sverre, E., et al.
Publicado: (2023) -
Medical and sociodemographic factors predict persistent smoking after coronary events
por: Sverre, Elise, et al.
Publicado: (2017)